The prevalence and influence of self-reported conflicts of interest by editorial authors of phase III cancer trials
- 1 September 2012
- journal article
- Published by Elsevier BV in Contemporary Clinical Trials
- Vol. 33 (5), 1019-1022
- https://doi.org/10.1016/j.cct.2012.05.011
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer researchCancer, 2009
- Evolution of the Randomized Controlled Trial in Oncology Over Three DecadesJournal of Clinical Oncology, 2008
- Disclosure of Conflicts of Interest by Authors of Clinical Trials and Editorials in OncologyJournal of Clinical Oncology, 2007
- Association between pharmaceutical involvement and outcomes in breast cancer clinical trialsCancer, 2007
- Pharmaceutical industry sponsorship and research outcome and quality: systematic reviewBMJ, 2003
- Scope and Impact of Financial Conflicts of Interest in Biomedical ResearchJAMA, 2003
- Assessing Faculty Financial Relationships With IndustryJAMA, 2000
- The uncertainty principle and industry-sponsored researchThe Lancet, 2000
- Scientific Journals and Their Authors’ Financial Interests: A Pilot StudyPsychotherapy and Psychosomatics, 1998
- Understanding Financial Conflicts of InterestNew England Journal of Medicine, 1993